Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ANIP: ANI Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
ANIP
The Story
ANIP
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+26.2% / yr
Operating margin
13.4%
ROIC
8.2%
Financially safe
Adequate
Debt / equity
0.58×
Interest coverage
3.9×
Current ratio
3.12×
Valuation
Unrated
P/E ratio
19.3×
ANI Pharmaceuticals, Inc.
ANIP
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
ANI Pharmaceuticals, Inc.
ANIP
NASDAQ
·
USD
·
Closed
$79.24
−1.48%
$79.24
−$1.19 (1.48%)
52W Range
45th
pctl
Volume
0.58×
avg
Mkt Cap
1.80B
USD
P/E
19.3
TTM
Div Yield
–
ann
52W Range
45th
pctl
Volume
0.58×
avg
Market Cap
1.80B
USD
P/E Ratio
19.3
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings